2026 NPPES data Neuromusculoskeletal Medicine & OMM Physician NPI 1790718138 M.D.
Verify on CMS →

KULVEEN SACHDEVA, M.D.

Neuromusculoskeletal Medicine & OMM Physician in SAN RAMON, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
5K
Medicare Part D claims · 604 beneficiaries · Neuromusculoskeletal Medicine & OMM Physician avg: 1K
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
0/100
▼ 83 pts below national avg 83.1 · [object Object]
Industry payments
$217.93
5 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

KULVEEN SACHDEVA, M.D. reported a CMS MIPS final score of 0/100 — below the 83.1 national average — and filed 4,608 Medicare Part D claims in 2023.

0/100
MIPS score · -83 vs avg
5K
Part D claims, 2023
93%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

KULVEEN SACHDEVA, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

0 0th percentile higher than 0% of 477,587 scored providers

0–10: 8,684 scored providers (2%). This entry sits in this band. 10–20: 3,008 scored providers (1%). Above this entry. 20–30: 3,069 scored providers (1%). Above this entry. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

KULVEEN SACHDEVA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about KULVEEN SACHDEVA, M.D.?

Below national average

NPI registry status

Active

Issued 07/09/2006

NPI 1790718138

Primary specialty

Neuromusculoskeletal Medicine & OMM Physician

Niche

1,235 US NPIs in this specialty

Medicare Part D claims

4,608 316% vs specialty avg

2023 prescription claims

Specialty avg: 1,107

MIPS final score

0/100 83.1% pts

Penalty band band

vs 83.1 national avg

Specialty distribution in California

How Neuromusculoskeletal Medicine & OMM Physician compares to other specialties among California providers

California providers

Neuromusculoskeletal Medicine & OMM Physician share within California

1. Neuromusculoskeletal Medicine & OMM Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Neuromusculoskeletal Medicine & OMM Physician share within California

Medicare quality performance — MIPS

KULVEEN SACHDEVA, M.D.'s 2023 MIPS final score plotted against the Neuromusculoskeletal Medicine & OMM Physician national average

Below national average
MIPS Final Score
0/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Neuromusculoskeletal Medicine & OMM Physician) — 0/100 vs national avg 83.1

0%100%National avg83%0%
MIPS final score (Neuromusculoskeletal Medicine & OMM Physician) — 0/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

KULVEEN SACHDEVA, M.D. appears in the CMS NPPES registry as a Neuromusculoskeletal Medicine & OMM Physician provider holding M.D. credentials at 5401 NORRIS CANYON RD STE 110, SAN RAMON, CA, 94583, with a listed phone of (925) 866-7252. NPI 1790718138 was issued on 07/09/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SACHDEVA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 4,608 prescription claims written by this provider, covering 604 Medicare beneficiaries and totaling roughly $1.2 million in drug spend, split 7% brand-name and 93% generic by claim count, with an opioid prescribing rate of 0.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.

Neuromusculoskeletal Medicine & OMM Physician is a narrow specialty nationwide, with 1,235 enrolled providers across 51 states and an average of 1,107 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5401 NORRIS CANYON RD STE 110
SAN RAMON, CA 94583

Provider Details

NPI 1790718138
Specialty Neuromusculoskeletal Medicine & OMM Physician
Credentials M.D.
Gender Female
NPI Issued 07/09/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

0
Final Score
Avg: 83.1
0
Quality

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for KULVEEN SACHDEVA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$218

Largest payer

Eisai Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to KULVEEN SACHDEVA, M.D.. To verify KULVEEN SACHDEVA, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

KULVEEN SACHDEVA, M.D. — brand share 7.0%
Specialty average (est.)

7% brand-name claims vs 93% generic, on 4,608 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

4,608
Total Claims
$1.2M
Total Drug Cost
604
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
8,492
Total Day Supply
251,737
Brand vs Generic
7% brand / 93% generic
Brand Drug Cost
$906K
Generic Drug Cost
$261K
Opioid Claims
41 (0.9% rate)

Patient Demographics

Average Patient Age
76.7 years
Avg HCC Risk Score
1.16
Gender Split
59% female / 41% male
Age Distribution
<65: 26, 65-74: 206, 75-84: 272, 85+: 100

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What KULVEEN SACHDEVA, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Gabapentin
423
Donepezil Hcl
417
Carbidopa-Levodopa
Carbidopa/Levodopa
357
Memantine Hcl
276
Escitalopram Oxalate
158
Levetiracetam
126
Rivastigmine
Rivastigmine Tartrate
111
Quetiapine Fumarate
110
Propranolol Hcl
102
Amitriptyline Hcl
100

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Neuromusculoskeletal Medicine & OMM Physician Overview

How KULVEEN SACHDEVA, M.D. fits within the Neuromusculoskeletal Medicine & OMM Physician landscape nationally.

1,235
Neuromusculoskeletal Medicine & OMM Physician Providers in US
51
States with Neuromusculoskeletal Medicine & OMM Physician
1,107
Avg Claims per Provider

KULVEEN SACHDEVA, M.D.'s 4,608 claims are above the specialty average of 1,107.

Nearby Neuromusculoskeletal Medicine & OMM Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as SACHDEVA.

Compare Neuromusculoskeletal Medicine & OMM Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is KULVEEN SACHDEVA, M.D.'s specialty?
KULVEEN SACHDEVA, M.D. specializes in Neuromusculoskeletal Medicine & OMM Physician and practices in SAN RAMON, California. Credentials: M.D..
How much does KULVEEN SACHDEVA, M.D. prescribe under Medicare Part D?
In 2023, KULVEEN SACHDEVA, M.D. wrote 4,608 Medicare Part D claims totaling $1.2M in drug costs for 604 beneficiaries.
What is KULVEEN SACHDEVA, M.D.'s Medicare quality score?
KULVEEN SACHDEVA, M.D. has a CMS MIPS Final Score of 0/100 (Quality: 0). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is KULVEEN SACHDEVA, M.D. located?
KULVEEN SACHDEVA, M.D. is located at 5401 NORRIS CANYON RD STE 110, SAN RAMON, CA, 94583. Phone: (925) 866-7252.
What is KULVEEN SACHDEVA, M.D.'s NPI number?
KULVEEN SACHDEVA, M.D.'s National Provider Identifier (NPI) is 1790718138, issued on 07/09/2006.
Does KULVEEN SACHDEVA, M.D. prescribe more brand-name or generic drugs?
KULVEEN SACHDEVA, M.D.'s prescribing is 7% brand-name and 93% generic drugs by claim count, with $906K in brand drug costs.
Does KULVEEN SACHDEVA, M.D. prescribe opioids?
Yes, KULVEEN SACHDEVA, M.D. had 41 opioid claims in 2023 with an opioid prescribing rate of 0.9%.
How many Neuromusculoskeletal Medicine & OMM Physician providers are there in the US?
There are 1,235 Neuromusculoskeletal Medicine & OMM Physician providers across 51 states in the US. The average Neuromusculoskeletal Medicine & OMM Physician provider writes 1,107 Medicare Part D claims per year.
What drugs does KULVEEN SACHDEVA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, KULVEEN SACHDEVA, M.D.'s most frequently prescribed drugs include Gabapentin, Donepezil Hcl, Carbidopa-Levodopa. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does KULVEEN SACHDEVA, M.D. accept Medicare?
KULVEEN SACHDEVA, M.D. appears in CMS Medicare data with 4,608 Part D claims and 604 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify KULVEEN SACHDEVA, M.D.'s credentials?
KULVEEN SACHDEVA, M.D.'s NPI is 1790718138 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology